Universal Biosensors Inc (UBI)-Product Pipeline Analysis, 2017 Update

GDME7173PD
Pages: 29
June 2017
Region : Asia
GlobalData
Equity Research Report

Select a License

Single User License

USD 750

Site License

USD 1500

Corporate User License

USD 2250

Details
Table Of Content
Licence Rights
Section Purchase
Products and Companies

Details

Summary

Universal Biosensors Inc (UBI) is a medical diagnostic company. The company researches, develops and manufactures in vitro diagnostic test devices that are used for professional and consumer point-of-care. The company is working with Siemens Healthcare to develop a range of products for the point-of-care coagulation market and will manufacture test strips for these products. UBI's major focus areas include coagulation testing, blood glucose testing and other electromechanical cell based tests. Its in-vitro diagnostic test devices are based on electrochemical cell technology platform. The company manages its research and development, and manufacturing operations through its subsidiary, Universal Biosensors Pty Ltd (UBS) in Melbourne. UBI is headquartered in Melbourne, Victoria, Australia.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Universal Biosensors Inc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Universal Biosensors Inc Company Overview 4

Universal Biosensors Inc Company Snapshot 4

Universal Biosensors Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Universal Biosensors Inc-Pipeline Analysis Overview 7

Business Description 7

Universal Biosensors Inc-Key Facts 7

Universal Biosensors Inc-Major Products and Services 8

Universal Biosensors Inc Pipeline Products by Development Stage 9

Universal Biosensors Inc Pipeline Products Overview 11

C-Reactive Protein Test 11

C-Reactive Protein Test Product Overview 11

Diagnostic Assay-Coagulation 12

Diagnostic Assay-Coagulation Product Overview 12

DNA/RNA Blood Glucose Test 13

DNA/RNA Blood Glucose Test Product Overview 13

Handheld POC Coagulation Testing System-Ambulatory Care 14

Handheld POC Coagulation Testing System-Ambulatory Care Product Overview 14

Immunoassay Test-D-Dimer 15

Immunoassay Test-D-Dimer Product Overview 15

PT-INR Testing System-Decentralised And Home Use 16

PT-INR Testing System-Decentralised And Home Use Product Overview 16

Universal Biosensors Inc-Key Competitors 17

Universal Biosensors Inc-Key Employees 18

Universal Biosensors Inc-Key Employee Biographies 19

Universal Biosensors Inc-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 21

Universal Biosensors Inc, Recent Developments 21

May 08, 2017: Commencement of Xprecia Stride Coagulation Analyser sales activities in the US market 21

Oct 04, 2016: Siemens Receives FDA Clearance of the Xprecia Stride Coagulation Analyzer 21

Jun 30, 2016: UBI appoints Craig Coleman as Non-Executive Director 22

Apr 21, 2016: Universal Biosensors Reports Q1 2016 Results 22

Apr 01, 2016: Universal Biosensors-Update 22

Mar 02, 2016: Universal Biosensors Appoints David Hoey as Non-Executive Director 23

Feb 19, 2016: Universal Biosensors Announces Retirement of CEO Paul Wright 23

Oct 15, 2015: Development Update: UBI PT-INR Testing System for decentralised and home use 24

Jul 23, 2015: Half Yearly Report and SEC Form 10Q for Q2 2015 24

May 13, 2015: Siemens Healthcare Diagnostics launches Xprecia Stride Coagulation Analyzer 25

Appendix 26

Methodology 26

About GlobalData 28

Disclaimer 28

List Of Figure

List of Figures

Universal Biosensors Inc Pipeline Products by Equipment Type 5

Universal Biosensors Inc Pipeline Products by Development Stage 9

List Of Table

List of Tables

Universal Biosensors Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Universal Biosensors Inc Pipeline Products by Equipment Type 5

Universal Biosensors Inc Pipeline Products by Indication 6

Universal Biosensors Inc, Key Facts 7

Universal Biosensors Inc, Major Products and Services 8

Universal Biosensors Inc Number of Pipeline Products by Development Stage 9

Universal Biosensors Inc Pipeline Products Summary by Development Stage 10

C-Reactive Protein Test-Product Status 11

C-Reactive Protein Test-Product Description 11

Diagnostic Assay-Coagulation-Product Status 12

Diagnostic Assay-Coagulation-Product Description 12

DNA/RNA Blood Glucose Test-Product Status 13

DNA/RNA Blood Glucose Test-Product Description 13

Handheld POC Coagulation Testing System-Ambulatory Care-Product Status 14

Handheld POC Coagulation Testing System-Ambulatory Care-Product Description 14

Immunoassay Test-D-Dimer-Product Status 15

Immunoassay Test-D-Dimer-Product Description 15

PT-INR Testing System-Decentralised And Home Use-Product Status 16

PT-INR Testing System-Decentralised And Home Use-Product Description 16

Universal Biosensors Inc, Key Employees 18

Universal Biosensors Inc, Key Employee Biographies 19

Universal Biosensors Inc, Subsidiaries 20

Glossary 27

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Universal Biosensors Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

We can't find products matching the selection.

Page 152 | May 2019

Kuwait Medical Device Market Outlook to 2022 - By Type (Diagnostic Imaging Products, Medical Disposables, Auxiliary Devices, Orthopedic Devices, Dental Products, Aesthetic Devices, Diabetic Products and Others)

Page 91 | December 2018

Singapore Medical Devices Market Outlook to 2022 - by Type of Medical Device (Consumables, Diagnostic Imaging, Patient Aids, Orthopedic & Prosthetics, Dental Products and Others)

Page 40 | June 2018

Europe POCT Devices Market Outlook to 2022 - by Geography (Western Europe & Eastern Europe), by Product (Blood Glucose POCT, Infectious POCT, Cardiac POCT, Rapid Coagulation POCT, Blood Gas & Electrolytes POCT, Hematology POCT, Pregnancy POCT, Urinal

Page 102 | June 2018

Vietnam Medical Devices Market Outlook to 2022 - By Equipments (Consumables, Diagnostic Imaging, Dental Products, Orthopedics and Prosthetics, Patient Aids and Other Medical Devices)

Page 54 | February 2018

Universal Biosensors Inc (UBI)-Product Pipeline Analysis, 2017 Update

Details